Medical Developments International Limited Medical Developments International Limited

Medical Developments International Limited

MVP

Clasificación en acciones #27371
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Precio por acción
$0.28211392
Capitalización bursátil
$31.78M
Cambio (1 día)
0.00%
Cambio (1 año)
-12.00%
País
AU
Comercio Medical Developments International Limited (MVP)

Categoría

Healthcare
EPS de Medical Developments International Limited (MVP)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Medical Developments International Limited, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Medical Developments International Limited desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras